Croissy-Beaubourg and Montpellier, January 26, 2017 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, announces that it has been selected by the Eurostars-2 program to receive financial support for…
Croissy-Beaubourg and Montpellier, January 24, 2017 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics, announces today its financial reporting schedule for 2017.Financial publications will be released after market close.…
LISA TRACKER®, the leading biotherapy monitoring range available in the global marketCroissy-Beaubourg and Montpellier, December 1, 2016 – Theradiag (ISIN: FR0004197747, ticker: ALTER, eligible for PEA-PME equity savings plans in France), a company specializing in…